Authors
Loading...
NAD(P)H oxidase inhibition may reduce Ang II-driven vascular inflammation; leaves open translation of rat findings to human hypertension trials.
Key points are not available for this paper at this time.
Liu et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: